Documentos de Santiago Nelson Vispo | REDI

Regresar

Mostrando 5 resultados de: 5

Filtros aplicados

Palabras Claves: "clinical trials"

Subtipo de publicación

Publisher

Therapeutic Innovation and Regulatory Science(3)

Pharmaceutics(1)

Área temáticas

Medicina y salud(5)

Enfermedades(2)

Dibujo técnico, materiales peligrosos(1)

Área de conocimiento

Biotecnología(1)

Medicina interna(1)

Salud Pública(1)

Año de Publicación

Origen

Palabras Claves

Nanomedicine(2)

Drug delivery system(1)

Biomedical science to tackle the COVID-19 pandemic: Current status and future perspectives

Abstract: The coronavirus infectious disease (COVID-19) pandemic emerged at the end of 2019, and was caused by

Palabras claves:

clinical trials, DIAGNOSTICS, Nanomedicine, prevention, Treatment, vaccines

Camilo Zamora-Ledezma, David F.C. Clavijo, Ernesto Medina Dagger, Federico L. Sinche, Frank Alexis, Santiago Nelson Vispo, Si Amar Dahoumane

CRISPR-Cas9: A Precise Approach to Genome Engineering

Abstract: In the last few decades, genomic manipulation has made significant progress as a result of the devel

Palabras claves:

bacterial adaptive defense system, clinical trials, CRISPR-Cas9, genetic engineering, NGS

Jorge E. Simón, Rodríguez Á.S., Santiago Nelson Vispo

Advances in Clinical Research in Ecuador

Abstract: Ecuador is undergoing a process of clinical research development and strengthening. At the turn of t

Palabras claves:

clinical research, clinical trials, Economic development, ECUADOR, Pharmaceutical

Castro K.A., Luis Santiago Escalante, Santiago Nelson Vispo, Thelvia I. Ramos Gómez

Peptide Phage Display: Molecular Principles and Biomedical Applications

Abstract: Phage display (PD) is a technology based on the presentation of functional exogenous peptides on the

Palabras claves:

Cáncer, clinical trials, Drug delivery system, infection diseases, peptide libraries, phage display

Karen Elizabeth Sánchez Blacio, Marlon S. Zambrano-Mila, Santiago Nelson Vispo

The Hitchhiker’s Guide to Human Therapeutic Nanoparticle Development

Abstract: Nanomedicine plays an essential role in developing new therapies through novel drug delivery systems

Palabras claves:

clinical trials, Immunotoxicity, Nanomedicine, Nanoparticles, pharmacokinetics, Preclinical, Regulatory aspects

Altamirano C., Katherine V. López-Aguilar, Leandro Santiago Padilla, Santiago Nelson Vispo, Thelvia I. Ramos Gómez, Toledo J.R., Villacis-Aguirre C.A.